The trademark application was filed by Clover Biopharmaceuticals Ireland Limited, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on October 7, 2021, and it was registered by office on January 14, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1659539 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on February 22, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for human use
Antibiotics
Vaccines
Antibodies
Anti-cancer preparations
Antivirals
Pharmaceutical preparations for treating respiratory diseases.
The mark was filed in class 42 with following description of goods:
Pharmaceutical drug development services
Pharmaceutical research services
Conducting early evaluations in the field of new pharmaceuticals
Biological research
Clinical trials
Research and development services in the field of antibiotics
Research and development services in the field of vaccines
Research and development services in the field of antibodies
Research and development services in the field of anti-cancer preparations
Research and development services in the field of antivirals
Research and development services in the field of respiratory diseases